Effect of Aged Garlic Extract (AGE) on Improving Coronary Atherosclerosis in People With Type 2 Diabetes Mellitus

Not Applicable

Completed

• Conditions: Endothelial Dysfunction; Coronary Arteriosclerosis; Type 2 Diabetes Mellitus
• Interventions: Dietary Supplement: Aged Garlic Extract (AGE); Dietary Supplement: Placebo

• Registration Number: NCT03931434
• Lead Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Brief Summary

The purpose of this research study is to see the effect of taking Aged Garlic Extract (AGE) on the progression of coronary plaque, a condition called atherosclerosis, in people diagnosed with Diabetes.

Detailed Description

This clinical trial is to determine on progression rates of low attenuation plaque under influence of Aged Garlic Extract as compared to placebo over the 1year period in individuals with Type 2 Diabetes Mellitus.The study also examines the effect of Aged Garlic Extract on endothelial function and arterial stiffness which was measured by cardio-ankle vascular index (CAVI) over the 3months period.

Study Timeline

• Study Start: 2016-02-23
• Primary Completion: 2018-05-07
• Study Completion: 2018-05-07
• Status Verified: 2019-04
• Study First Submitted: 2019-04-25
• Study First Submitted QC: 2019-04-29
• Last Update Submitted: 2019-04-29
• Study First Posted: 2019-04-30
• Last Update Posted: 2019-04-30

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 88

Inclusion Criteria

• Age 30-75 years
• Known Diabetes Mellitus (HgA1c >6.5%, fasting blood sugar >125 mg/dl, taking anti- diabetes medications)
• Subjects must provide written informed consent after the scope and nature of the investigation has been explained to them
• Calcium Score >20 at baseline

Exclusion Criteria

• A contraindication to AGE including: known hypersensitivity to drug.
• Any unstable medical, psychiatric or substance abuse disorder that in the opinion of the investigator or principal investigator is likely to affect the subject's ability to complete the study or precludes the subject's participation in the study
• Weight in excess of 350 pounds
• Bleeding disorder
• History of known coronary artery disease, myocardial infarction, stroke or life- threatening arrhythmia within the prior six months
• NYHA Class II- IV heart failure
• History of malignancy within the last 5 years (other than skin cancer) or evidence of active cancer which would require concomitant cancer chemotherapy
• Serum creatinine > 1.4 mg/dl
• Triglycerides > 400 at visit 1
• Drug or alcohol abuse, or current intake of more than 14 standard drinks per week
• Concurrent enrollment in another placebo-controlled trial
• Partial ileal bypass or known gastrointestinal disease limiting drug absorption
• Current tobacco use
• Current use of anticoagulants (except for anti-platelet agents)
• Renal failure
• History of hypertensive encephalopathy or cerebrovascular accident
• Hematological or biochemical values at screening outside the reference ranges considered as clinically significant in the opinion of the investigator or PI
• Pregnancy

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Aged Garlic Extract (AGE)	Aged Garlic Extract (AGE)	2400mg of Aged Garlic Extract (AGE)
Placebo	Placebo	The Placebo does not contain any Aged Garlic Extract (AGE)

Primary Outcome Measures

Name	Time	Method
Progression rates of low attenuation plaque under influence of Aged Garlic Extract (AGE) as compared to placebo.	12 months	Progression rates of low attenuation plaque under influence of Aged Garlic Extract (AGE) as compared to placebo.

Secondary Outcome Measures

Name	Time	Method
Rate of change in inflammatory biomarkers (CRP,IL-6)	12 months	Rate of change in inflammatory biomarkers
Rate of change in endothelial function	3 months and 12 months	Endothelial Function and arterial stiffness measured by cardio-ankle vascular index (CAVI)

Trial Locations

Locations (1)

Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center; 🇺🇸 Torrance, California, United States